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Abstract Obesity and binge eating disorder are common in individuals with psychotic
disorders. Eating and weight-related cognitions are known to influence eating behaviors.
The study was designed to assess the psychometric properties of the Mizes Anorectic
Cognitions Questionnaire (MAC-R) in patients with psychotic disorders. Binge eating
disorder (BED), body mass index (BMI), the MAC-R and the three factor eating ques-
tionnaire (TFEQ) were assessed in 125 patients with a diagnosis of schizophrenia or
schizoaffective disorder. Whereas the MAC-R has not acceptable psychometric properties,
a brief version of the MAC-R (BMAC) has good psychometrical properties and is corre-
lated with TFEQ and BMI. Binge eating disorder is also correlated to the Rigid Weight
Regulation and Fear of Weight Gain subscale. The BMAC is a useful brief measure to
assess eating and weight related cognitions in people with psychotic disorders.
Keywords Antipsychotic drugs  Weight gain  Obesity  Binge eating disorder 
Mizes anorectic cognitions  Factor structure
Introduction
Overweight and obesity are common in individuals with schizophrenia [1, 2] and are linked
to antipsychotic drugs (AP) [3]. AP induced weight gain is related to an increase in global
caloric intake possibly associated to alterations of the feeling of satiety [4] and possible
alterations of peripheral metabolism signals [5].
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Cognitive-behavioral conceptualizations on eating-disorders and obesity highlighted the
role of dysfunctional cognitions (i.e. restraint: the intention to consciously restrict food
intake in order to maintain body weight or to promote weight loss) [6] in clinical and non-
clinical populations without psychotic disorders [7–10]. These cognitions were associated
with overeating under different conditions including an exposition to food preload, foods-
related cues, alcohol and dysphoric moods [10–12]. Levels of eating disorder cognitions
have been shown to persist following a moderate calorie restricted diet [13] and predict
post treatment relapse [8]. In addition, several studies showed a correlation between dietary
restrained eating and binge eating disorder (BED) [7], which is associated with obesity
[9, 14].
These cognitions, assessed with the revised Mizes Anorectic Cognitive Questionnaire
(MAC-R) [15], were also found in overweight patients treated with antipsychotic drugs
[16].
In populations without psychotic disorders, the MAC-R [15] has been showed to be a
relevant self-report to assess cognitions related to eating disorders. This questionnaire was
correlated with other eating disorder questionnaires such as the Eating Disorders Inventory
[17] and the Restraint scale [18]. However, the psychometrical properties of the MAC-R
remain unclear. Indeed, a previous study [19] fails to confirm the factor structure of the
MAC-R on an undergraduate sample and had secondly extracted a brief 12-items version
of this questionnaire (Brief Mizes Anorectic questionnaire: BMAC).
The MAC-R was already used among people with psychotic disorders and it was
furthermore found that a cognitive and behavioral treatment including interventions aiming
to change these cognitions was effective in this population [20].
The study aims to investigate the psychometric properties of the MAC-R in people with
psychotic disorders which has not yet been realized despite the clinical relevance of this
instrument.
Methods
Participants and Procedure
Participants were recruited in outpatient and day hospital units in Lausanne, Switzerland.
Inclusion criteria were a DSM-IV diagnosis of schizophrenia or schizoaffective disorder.
Exclusion criteria were opiate, alcohol or cocaine dependence and impossibility to give
written informed consent. Psychiatric diagnoses were established according to the DSM-IV
criteria by psychiatry residents and a senior psychiatrist, based on clinical interviews. The
present study is part of a study approved by the Lausanne Ethical committee. All patients
gave written informed consent.
Measures
The participants were assessed with the instruments described below.
The Revised Mizes Anorectic Cognitive Questionnaire (MAC-R)
The French MAC-R consisted of 24 items translated from the English into French and then
back-translated by an independent English-French bilingual. All discrepancies identified
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were discussed until a satisfactory solution was found. The MAC-R assess three specific
dimensions: (1) Rigid Weight regulation and Fear of Weight gain (RWFW), (2) Self-
Control as the basis of Self-Esteem (SCSE), and (3) Weight and eating behavior as the
basis of Approval From Others (WAFO). Participants responded to each items using a
Likert-scale ranging from 1 = ‘‘Strongly disagree’’ to 5 = ‘‘Strongly agree’’.
Three Factor Eating Questionnaire (TFEQ)
The TFEQ [21] is a widely used 51 item self-report questionnaire (with a true–false
response format) intended to assess three dimensions of eating behaviors: ‘‘Restraint’’,
‘‘Disinhibition’’ (susceptibility to periodic disinhibition of control over eating) and per-
ceived ‘‘Hunger’’.
Dietary restraint as measured by TFEQ reflects behavioral mechanisms for restraining
food intake which differs from the cognitive restraint dimension (the intention to con-
sciously restrict food intake) of the MAC-R [21].
Eating Disorders
Bulimia nervosa, anorexia and BED were assessed through a clinical interview using
DSM-IV criteria (SCID-IV) [22].
Body Mass Index (BMI)
Height and body weight were measured, BMI was then calculated.
Results
Participants
One participant with a bulimia nervosa was excluded from the analysis. In fine, (40 day-
hospital patients and 85 outpatients) 125 subjects (30.5% with a BED) were included in the
study (Table 1). Table 1 reports demographical characteristics, diagnosis, BMI, and anti-
psychotic drug medication of the sample. Due to its longer format, the TFEQ was available
for only 55 patients. The other measures, with the exception of few missing data, were
available for the whole sample.
Confirmatory Factor Analysis of the MAC-R
The psychometric properties of the MAC-R were analyzed using Confirmatory Factor
Analysis (CFA) computed with Mplus [23], using the Full-Information Maximum Like-
lihood (FIML) estimator for missing data (12 patients have one or more missing data on the
MAC-R). To evaluate the overall fit of each model to the data, we used the Mplus MLR
chi-square test of model fit that is robust to non-normal data. In addition to the chi-square,
three classical fit indices which depend on conventional cut-off were used: The Root Mean
Square Error of Approximation (RMSEA), the Standardized Root Mean Square Residual
(SRMR), and the Comparative Fit Index (CFI). Hu and Bentler [24] recommended values
of RMSEA below .06, SRMR below .08, and CFI above .95. Two models were then
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computed: (1) a model based on the original three factor model of the MAC-R (Model 1A);
and (2) a model assessing the fit of a unique latent variable composed of all the items of the
MAC-R (Model 1B). Results showed that the two models computed have a poor fit. Then,
we chose to compute another model (Model B) based on a study of Osman et al. [19].
Indeed, these authors also failed to validated the MAC-R and have validated a short three-
factor model of this questionnaire based on 12 items: The BMAC. Results showed Model
C has a good fit (Table 2). Internal reliability (Cronbach’s alpha) of the BMAC range from
relatively poor (SCSE: a = .54; RWFW: a = .55) to acceptable (WAFO: a = .63).
However, the internal reliability of the whole scale is acceptable (a = .65).
Correlation Analysis
Means, standard deviations, and Cronbach’s alpha for the BMAC, the TFEQ, and the BMI
are reported in Table 3 for participants with no missing data.
Table 1 Baseline characteristics
of the sample
Group total
(N = 125)
Age 35.7 years (SD 10.9)
Gender (%) 57.6% women
Living in a residential setting 19%
Unemployed (%) 78.5%
Time since first contact with psychiatric
services
8.6 years (SD 6.2)
Binge eating disorder 30.5%
Body mass index, mean (SD) 29.7 (SD 5.3)
MAC-R total score 72. 6 (SD 12.5)
Diagnosis
Schizophrenia 93.8%
Schizoaffective disorders 6.2%
Antipsychotic drugs (%)
(one or more drugs per patient)
Olanzapine 38.5%
Risperidone 16%
Clozapine 13.2%
Quetiapine 14%
Aripiprazole 13.2%
Amisulpride 5.3%
Classical antipsychotic 12%
Table 2 Fit indices of the confirmatory factor analyses
Model v2 df RMSEA SRMR CFI
Model 1A (MAC-R 1 factor) 559.74*** 252 .10 .11 .35
Model 2A (MAC-R 3 factors) 427.44*** 249 .076 .10 .62
Model B (BMAC) 62.54 51 .043 .075 .92
*** P \ .001
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Correlation analysis was computed to explore the relationship between the BMAC and
the TFEQ, BMI, gender, and the presence of a BED. Pairwise treatment of missing data
was used. Confirming or rejecting hypotheses based on P-value has been shown to be
problematic because P-value depends on both effect sizes and sample size. Thus, following
suggestions by several authors [25], effect sizes were reported within 95% confident
interval (CI) and used in the interpretation of the results. The relationships between gender
and the occurrence of binge eating with the other variables were considered by computing
Pearson’s point-biserial correlation (rpb) for dichotomic variables. All correlations are
reported in Table 4. In particular, significant correlations appeared between the BMAC
total score and the TFEQ total score (.35), the Hunger dimension of the TFEQ (.34), and
the BMI (.35). Considering the subscales of the BMAC, correlations were found between
the SCSE facet of the BMAC and both the total score of the TFEQ (.36) and the Restraint
facet of the TFEQ (.38), whereas the RWFW facet of the BMAC was related to the Hunger
dimension of the TFEQ (.34). In addition, BMI was positively related to both the SCSE
(.34) and the RWFW (.27) facets of the BMAC. Considering gender differences, results
showed that female have higher scores on the SCSE facet of the BMAC (.24). Finally, the
RWFW facet of the BMAC is related to the occurrence of a diagnosis of binge eating
disorder (.23).
Discussion
The aim of the present study was to validate the MAC-R in a French speaking sample of
patients with psychotic disorder. Similarly as in the study of Osman et al. [19], we failed to
confirm a one factor as well as a three factors model of the MAC-R. However, based on
findings of Osman et al. [19], we showed that the BMAC (12 items which correspond to the
three-factor model of the original MAC-R) has good psychometrical properties. Never-
theless, although the whole scale has an acceptable internal reliability, two of its subscales
have lower internal reliability. These results could be due to the low number of items in the
BMAC subscales and to a moderate sample size including variability in BED diagnosis.
Table 3 Descriptive statistics
a Females (N = 72) Males (N = 53)
M SD M SD
BMAC .65 37.68 6.84 35.06 7.68
BMAC–SCSE .54 15.48 3.31 13.79 3.50
BMAC–WAFO .63 10.62 3.54 9.73 2.94
BMAC–RWFW .55 11.48 3.89 11.75 3.84
TFEQ .71 27.75 6.55 23.77 6.16
TFEQ-Restraint .80 11.79 4.28 8.33 4.68
TFEQ-Disinhibition .62 8.93 3.35 7.97 2.71
TFEQ-Hunger .68 7.04 3.14 7.47 2.89
BMI 29.92 5.58 29.49 4.79
a Cronbach’s alpha; M mean; SD standard deviation; BMAC total score on the Brief Mizes Anorectic
Cognitions Questionnaire; BMAC–SCSE BMAC–Self-Control and Self-Esteem; BMAC–WAFO BMAC–
Weight and Approval from Others; BMAC–RWFW BMAC–Rigid Weight Regulation and Fear of Weight
Gain; TFEQ total score on the Three-Factor Eating Questionnaire; BMI body mass index
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The BMAC was correlated to the total score and the Hunger dimension of the TFEQ.
This latter is also correlated with the BMAC–RWFW subscale. This relationship may
support the assumption that people who scored higher on BMAC–RWFW subscale were at
an increasing risk of heavy hunger perception (linked to diet-related behavior). It is also
possible that people with more hunger perception (possibly associated to AP) are at risk to
develop these cognitions. Interestingly, the BMAC–RWFW subscale was also associated
with BED.
Furthermore, as previously found in a population with psychotic disorder, the BMAC
was also correlated to the BMI [16], highlighting the possible interest of the BMAC in this
population in consideration that change in cognitions may enhance weight loss and lower
BED [20]. Further studies documenting the scale’s sensitivity to changes in body weight
and eating behaviors are warranted.
Conclusion
In conclusion, the BMAC has acceptable psychometrical characteristics in people with
psychotic disorders. The BMAC should be a useful tool in clinical practice in this
population.
Table 4 Pearson correlations (within their 95% CI)
BMAC BMAC–SCSE BMAC–WAFO BMAC–RWFW
BMAC–SCSE .69a (.57, .77)
N = 113
BMAC–WAFO .62a (.50, .72)
N = 113
.15 (-.04, .32)
N = 118
BMAC–RWFW .73a (.64, .81)
N = 113
.27a (.10, .43)
N = 116
.17 (-.01, .37)
N = 115
TFEQ .35a (.08, .57)
N = 54
.36a (.10, .57)
N = 55
.24 (-.03, .47)
N = 55
.22 (-.05, .46)
N = 54
TFEQ-Restraint .22 (-.07, .47)
N = 54
.38a (.13, .59)
N = 55
.15 (-.12, .40)
N = 55
-.03 (-.29, .25)
N = 54
TFEQ-Disinhibition .14 (-.15, .40)
N = 54
-.01 (-.27, .26)
N = 55
.09 (-.18, .35)
N = 55
.19 (-.08, .44)
N = 54
TFEQ-Hunger .34a (.07, .56)
N = 54
.21 (-.06, .49)
N = 55
.20 (-.07, .44)
N = 55
.34a (.08, .56)
N = 54
Genderb 2.18 (-.35, .00)
N = 118
-.24a (-.40, -.07)
N = 121
-.13 (-.31, .05)
N = 120
.04 (-.15, .21)
N = 118
BMI .31a (.13, .47)
N = 118
.34a (.17, .49)
N = 121
.02 (-.16, .20)
N = 120
.27a (.09, .43)
N = 118
Binge eatingb .14 (-.05, .32)
N = 118
.05 (-.13, .23)
N = 121
-.05 (-.23, .13)
N = 120
.23a (.05, .39)
N = 118
N = sample size for each correlation. Pairwise treatment of missing data
BMAC total score on the Brief Mizes Anorectic Cognitions Questionnaire; BMAC–SCSE BMAC–Self-
Control and Self-Esteem; BMAC–WAFO BMAC–Weight and Approval from Others; BMAC–RWFW
BMAC–Rigid Weight Regulation and Fear of Weight Gain; TFEQ total score on the Three-Factor Eating
Questionnaire; BMI body mass index; Binge eating diagnostic of binge eating disorders
a 0 not included in the 95% confidence interval
b Pearson’s point-biserial correlation (rpb)
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